Korro Bio, Inc.
KRRO
$12.35
-$0.11-0.88%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -10.32% | -0.95% | 3.79% | -11.60% | 23.08% |
Total Depreciation and Amortization | -2.23% | 44.86% | 19.97% | -0.69% | -26.29% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 23.94% | 15.50% | -42.13% | -7.83% | -18.13% |
Change in Net Operating Assets | -134.62% | 280.69% | -36.26% | 189.82% | -734.65% |
Cash from Operations | -226.24% | 53.43% | -10.29% | 33.34% | -3.71% |
Capital Expenditure | 91.80% | 70.23% | 18.17% | -6.24% | -239.03% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2,605.71% | 82.95% | 92.02% | -- | -- |
Cash from Investing | 1,285.57% | 78.02% | 87.72% | -1,724.86% | -239.03% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -81.55% | 28.02% | -98.92% | 48,501.44% | -99.91% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -81.55% | 28.02% | -98.92% | 48,501.44% | -99.90% |
Foreign Exchange rate Adjustments | -- | -400.00% | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | 200.00% | -- | -- | -- |
Net Change in Cash | 191.10% | 66.61% | 43.47% | -80.65% | -122.46% |